• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod: NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Naturvetenskap och teknik
    2. Matematik och naturvetenskap
    3. Biologi

    AI in Breast Cancer Stem Cells and Proteomics

    Precision Oncology Perspectives

    AvManzoor Ahmad Mir,Hina Qayoom Khan

    Häftad, Engelska, 2026

    1 826 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    AI in Breast Cancer Stem Cells and Proteomics: Precision Oncology Perspectives explores the intersection of artificial intelligence, cancer stem cell biology, and proteomics to address the persistent challenges of relapse, metastasis, and therapy resistance in breast cancer. This book provides a translational framework for precision oncology through advanced computational and molecular approaches. It gives insight into the biology of breast cancer stem cells (BCSCs), their heterogeneity, and the role of proteomics in identifying biomarkers and therapeutic targets. The integration of AI enables predictive modeling, drug resistance profiling, and multi-omics data analysis, offering novel insights into personalized treatment strategies. Academics benefit from a comprehensive, interdisciplinary resource that bridges cancer biology, bioinformatics, and clinical applications.

    The book equips researchers, clinicians, and students with case studies, algorithmic tools, and practical workflows to translate proteomic data into actionable medical interventions.

    • . Provides Al-driven frameworks for analyzing proteomic data in breast cancer stem cells
      . Explores posttranslational modifications and protein-protein interactions as therapeutic targets
      . Offers interdisciplinary case studies linking computational biology with clinical oncology

    Produktinformation

    • Utgivningsdatum:2026-06-26
    • Mått:191 x 235 x 17 mm
    • Vikt:450 g
    • Format:Häftad
    • Språk:Engelska
    • Antal sidor:338
    • Förlag:Elsevier Science
    • ISBN:9780443491092

    Utforska kategorier

    • Biologi inom Naturvetenskap och teknik

    Mer om författaren

    Dr. Manzoor Ahmad Mir holds a Master's in Zoology from HNBG Central University and completed his Ph.D. in Immunology at Jawaharlal Nehru University, New Delhi, and CSIR-Institute of Microbial Technology, Chandigarh. His research focuses on cancer biology, combination therapy in breast cancer, and tuberculosis immunology. Dr. Mir has published over 50 high-impact research papers and book chapters. He has authored more than 15 books with international publishers of repute. He serves on the editorial boards of prestigious journals. He is a member of several scientific organizations, including the American Association of Cancer Research and the Royal British Society. He has received the TARE Fellowship and the SRFP-2019 from the Indian Science Academies. Dr. Mir teaches Cancer Biology and Immunology at the University of Kashmir, where he heads the Department of Bioresources. Dr. Hina Qayoom is an accomplished researcher and academic currently serving as Assistant Professor in the Department of Bioresources, School of Biological Sciences, Amar Singh College, Cluster University, Jammu & Kashmir. She earned her Ph.D. in Bioresources from the University of Kashmir, specializing in Cancer Biology, where her research centered on targeting breast cancer using natural compounds with anti-cancer potential. Her doctoral work, acclaimed internationally, was selected for presentation at the prestigious ASCO 2024 Conference and published in the Journal of Clinical Oncology (Impact Factor 45.3). With over 78 peer-reviewed publications, an H-index of 18, and numerous articles in high-impact journals such as Cell Communication and Signaling, Biomedicine & Pharmacotherapy, Frontiers in Pharmacology, and Critical Reviews in Oncology/Hematology, Dr. Qayoom has made significant contributions to understanding breast cancer pathogenesis, stemness, and therapy resistance. Her work explores some of the most challenging aspects of cancer progression and therapy resistance, contributing significantly to the advancement of targeted cancer therapeutics.

    Innehållsförteckning

    • 1: Introduction to breast cancer stem cells and tumor heterogeneity2: Breast cancer stem cells across subtypes: Biology, challenges, and recent advances3: Proteomics in breast cancer: Technologies and applications4: Foundations of artificial intelligence in biomedical research5: Artificial intelligence for breast cancer stem cell characterization imaging and diagnostics6: Proteomic biomarkers and artificial intelligence–based predictive models7: Artificial intelligence for drug resistance and therapy response prediction in breast cancer stem cells8: Multiomics integration with artificial intelligence: From bench to bedside in breast cancer9: Interface between breast cancer stem cells and immunotherapy: Implications for personalized medicine with case studies10: Future directions: Smart oncology and personalized medicine